I want to add to the praise for the healthcare workers and first responders who are literally our front line in fighting this war we are in against a virus called COVID-19. As a retired medical technologist, I know that drive to do all we can to save the lives of others and not stopping for breaks or meals or even sleep until the work is done. I, thank God, was never in a battle that went on for days and weeks and now months, nor one where my life was at risk everyday when I went to work. Each and every one of you is a hero beyond compare.
In this same war, I am thinking we have not expressed enough praise for another group of frontline workers: those who are working in our grocery stores, hardware stores, drug stores and restaurants to keep us supplied with the essentials we need through this crisis. You are also at higher risk of being exposed than those of us who get to stay home. In positions that have been taken for granted by so many of us in our busy lives, we can now see you for the hugely important role you have always played in keeping society moving smoothly. Thank you.
Support for the most vulnerable
I am writing you to urge the support of legislation that addresses the needs of the most vulnerable:
1) $60 billion for the charitable sector and the construction of a mechanism for a rapid infusion of cash to those organizations serving immediate needs in communities while facing lost and declining revenue due to the pandemic.
2) Create a universal charitable deduction and allow post-March 1, 2020, donations to be claimed on 2019 taxes and future tax returns.
3) Clarify that charitable nonprofits of all sizes are able to participate in the emergency small business loan program by using the tax-law definition of charitable organizations (Sec. 501(c)(3) public charities).
4) Remove the cap on the number of employees and the language excluding nonprofits from receiving Medicaid reimbursements.
5) Increase funding for the Emergency Food and Shelter Program from the existing FY 2020 $125 million to $250 million to help people experiencing dire poverty.
6) Temporarily increase the maximum SNAP benefit.
7) Increase funding to prevent further homelessness. Provide an additional $15 billion for McKinney-Vento Emergency Solutions Grants and $5 billion for short-term rental assistance, like the Disaster Housing Assistance Program.
Thank you for acting in the welfare of the most vulnerable. Our society can only be as strong as our weakest links.
Making a false supposition
In Kenneth Gordons March 26 letter, (Facts vs. Hysteria), he maintained a false supposition: that COVID-19 is a form of flu. COVID-19 is not a form of flu, it is more akin to another coronavirus, the very deadly SARS (Severe Acute Respiratory Syndrome).
COVID-19 is a novel coronavirus, which is an infectious respiratory illness as is influenza; but this is a brand new virus. That means unlike the flu, which has a vaccine and several pharmaceutical therapies (including oseltamivir phosphate or Tamiflu), there are no vaccines or medicines available to treat the illness yet. Clinical trials for effective treatments and vaccines takes time. Another major concern is because COVID-19 is so new, scientists and medical researchers do not yet know if there are any long-term medical implications with this new virus or how frequently it mutates.
What the medical community does know is this new virus kills at a higher rate than influenza. Currently, the Journal of the American Medical Association estimates the virus is killing at a rate of 2.7 percent compared to a death rate of 1 percent for influenza, although the death rate in Italy is 7.2 percent. The World Health Organization is currently saying little slows this bug down, except for being well informed: Social distancing, sneezing/coughing into elbows and people being vigilant in not touching their face plus hand washing, and paying attention to any symptoms.
So, rather than worry about going back to work, instead consider your fellow humans while you may only show few or no symptoms, that germ you pass on may kill another person. Is going back to work fast really worth that risk?
Knowing it is all for the best
I am always thinking of ways to keep in touch with old friends and family from afar, so I am using this letter to the editor to more widely let known I am fine and am not affected yet by COVID 19.
Because of my interest in history, I have been thinking about other pandemics such as typhoid fever and polio and am encouraged by the fact that these diseases are no longer a threat. My grandfather, I believe, contracted typhoid fever from drinking contaminated water in the Wisconsin Dells.
And I remember how relieved I was during the polio epidemic to finally be able to take polio vaccine. We have come a long way with penicillin other miracle drugs, and I want to put in a plug for the advances in regenerative medicine now on the horizon, specifically stem cell therapy that I underwent this past year. One of the advantages of that is that it only took a half day and I could avoid a prolonged hospital stay. With the fear of contamination and spread of viruses, that was significant for me. I miss seeing you all but know it is for the best.
Drinking poison wastheir own mistake
Propylene glycol is used in many processed foods. Ethylene glycol is the main ingredient in antifreeze. They have similar names, but you wouldnt want to drink antifreeze. That would be stupid. Im sure that Charlie Powell (Tooth & Nail, Daily News), who I believe has a personal acquaintance with veterinarians at WSU, has seen what happens to dogs that dip their tongues in antifreeze.
Recently, we learned of an unfortunate couple of people who tried to self-medicate by drinking poison. The poison has a name similar to a common drug that could be an effective treatment for COVID-19. That is very sad, but obviously it was less than wise.
The drug in question has been safely used for decades to treat a variety of ailments, and doctors around the world have seen promising results against the new coronavirus. Mr. Powell, in his March 28 column, notes that there is an elected official who has mentioned this hopeful development, and then clearly suggests that the elected official is responsible for the actions of those unfortunately mistaken people. Negative, Mr. Powell!
People need to be aware of what they are doing, and if they purposely drink poison, its their own mistake. Theirs alone. Sad, but true.
See the original post here:
LETTERS TO THE EDITOR | Opinion - Moscow-Pullman Daily News
- Stem Cells Applications in Regenerative Medicine and Disease ... - December 6th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 6th, 2024
- Master of Science in Regenerative Medicine and Entrepreneurships FUSION program information session - The Daily | Case Western Reserve University - December 6th, 2024
- BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire - December 6th, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 6th, 2024
- University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness - University of... - December 6th, 2024
- Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug... - December 6th, 2024
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023
- Active Wound Care Market Rising demand for Skin Substitutes to boost the industry (2023-2033) | CAGR of 5.5% - EIN News - March 21st, 2023
- Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% - By PMI - EIN News - March 21st, 2023
- ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical VHH to address an unmet medical... - February 8th, 2023
- A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field - Yahoo Finance - October 15th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 15th, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 15th, 2022
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 15th, 2022
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 15th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - GlobeNewswire - October 15th, 2022
- Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022 -... - October 15th, 2022
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 15th, 2022
- Cell therapy weekly: Ray Therapeutics and Forge Biologics expand partnership - RegMedNet - October 15th, 2022
- FDA Expands Oversight of Cell and Gene Therapies - Pharmaceutical Technology Magazine - October 15th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Business Wire - October 15th, 2022
- The Health Benefits Of Sea Moss, According To Experts - Forbes - October 15th, 2022
- ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of ... - The Bakersfield Californian - October 15th, 2022
- Pain Management & Regenerative Medicine Specialists DFW - September 4th, 2022
- Tissue Engineering and Regenerative Medicine - National Institute of ... - September 4th, 2022
- First U.S. patient receives autologous stem cell therapy to treat dry AMD - National Institutes of Health (.gov) - September 4th, 2022
- International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt - Construction Review - September 4th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - September 4th, 2022
- Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic - BioSpace - September 4th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 4th, 2022
- TikoMed's ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all... - September 4th, 2022
- Frequency Therapeutics to Participate in September Investor and Medical Conferences - Business Wire - September 4th, 2022
- Can the immortal jellyfish teach us how to reverse aging? - Earth.com - September 4th, 2022